Parx produces synthetic yarn with antiviral and antimicrobial properties

Clients of Parx Materials have taken the lead in integrating the company’s unique technology into synthetic yarns – a 100 per cent polypropylene yarn with the specification, 55D/48F. 

Yarns or textiles produced with this technology have been thoroughly tested by independent laboratories with proven efficacy, successfully integrating the Parx technology to incorporate an intrinsic and non-migrating antimicrobial and antiviral performance. Organisms tested include H1N1 virus – whereby a 99.99% reduction of was measured in 8 hours; E. coli; Staphylococcus aureus; Ahemolytic streptococcus; Klebsiella pneumaniae; Pneudomonas aeruginosa; and Salmonella enterica subsp. Enterica.

The Parx Materials technology relies on a non-toxic, naturally occurring, biocompatible element that is integrated in the material to modify or improve the mechanical/physical properties of the materials, making them resistant to the adhesion and proliferation of bacteria, viruses, moulds, fungi, biofilm and fouling.

The technology does not involve any toxic chemical and is not migrating out. As the technology is not leaching away or wearing off and nothing is consumed, the technology lasts throughout the entire lifetime of the product.

The manufacturer involved verified the mechanical/physical properties of the yarns, comparing them with their original production without the technology and they have found no difference in characteristics – and the yarn upholds the quality level as originally designed by the manufacturer.

Antimicrobial and antiviral tests have been performed by SGS laboratories and the Guang Zhou Institute of Microbiology.